Successful treatment of oesophageal candidiasis by micafungin: a novel systemic antifungal agent (Q33980499)

30 July 2017

Successful treatment of oesophageal candidiasis by micafungin: a novel systemic antifungal agent (English)

1 reference

30 July 2017

1 reference

K Pettengell

1

1 reference

30 July 2017

J Mynhardt

2

1 reference

30 July 2017

T Kluyts

3

1 reference

30 July 2017

W Lau

4

1 reference

30 July 2017

D Facklam

5

1 reference

30 July 2017

D Buell

6

1 reference

30 July 2017

FK463 South African Study Group

7

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 August 2004

1 reference

Alimentary Pharmacology & Therapeutics

30 July 2017

1 reference

30 July 2017

20

1 reference

30 July 2017

4

1 reference

30 July 2017

475-481

1 reference

Natural history of opportunistic disease in an HIV-infected urban clinical cohort

30 July 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02083.X

Acquired immunodeficiency syndrome with severe gastrointestinal manifestations in Haiti

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02083.X

Acquired immunodeficiency syndrome in a heterosexual population in Zaire

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02083.X

Diagnosis and treatment of oropharyngeal candidiasis in patients infected with HIV: a critical reassessment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02083.X

Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02083.X

Identification of immune-related protein kinases from mosquitoes (Aedes aegypti).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02083.X

Discovery of novel antifungal (1,3)-beta-D-glucan synthase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02083.X

Antifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02083.X

In vitro antifungal activity of FK463, a new water-soluble echinocandin-like lipopeptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02083.X

Comparative antifungal activities and plasma pharmacokinetics of micafungin (FK463) against disseminated candidiasis and invasive pulmonary aspergillosis in persistently neutropenic rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02083.X

Efficacy of FK463, a new lipopeptide antifungal agent, in mouse models of disseminated candidiasis and aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02083.X

A randomized double-blind study of caspofungin versus amphotericin for the treatment of candidal esophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02083.X

10.1111/J.1365-2036.2004.02083.X

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference